Literature DB >> 9068936

Sertraline. Chronopharmacokinetics and the effect of coadministration with food.

R A Ronfeld1, K D Wilner, B A Baris.   

Abstract

Two nonblinded single-dose randomised 3-way crossover studies were conducted in healthy male volunteers to determine the effect of the time of administration (morning vs evening) and the effect of food on the pharmacokinetics of sertraline tablets. There were no significant treatment effects on the mean area under the plasma concentration-time curve (AUC), mean peak plasma sertraline concentration (Cmax), mean time to reach Cmax (tmax), mean terminal elimination half-life, or the mean elimination rate constant in either study. The results of these 2 studies show that the bioavailability and elimination of sertraline tablets are not influenced by the time of administration or administration with or without food. Thus, sertraline tablets offer the flexibility of morning or evening administration, to patients in the fasting or nonfasting state.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9068936     DOI: 10.2165/00003088-199700321-00008

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  7 in total

Review 1.  Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.

Authors:  P Benfield; A Ward
Journal:  Drugs       Date:  1986-10       Impact factor: 9.546

2.  Automated gas chromatographic-electron-capture assay for the selective serotonin uptake blocker sertraline.

Authors:  L M Tremaine; E A Joerg
Journal:  J Chromatogr       Date:  1989-11-24

3.  Absorption of paroxetine under various dietary conditions and following antacid intake.

Authors:  W H Greb; M A Brett; G Buscher; H D Dierdorf; H W von Schrader; D Wolf; G Mellows; B D Zussman
Journal:  Acta Psychiatr Scand Suppl       Date:  1989

Review 4.  Influence of food on the presystemic metabolism of drugs.

Authors:  A Melander; D Lalka; A McLean
Journal:  Pharmacol Ther       Date:  1988       Impact factor: 12.310

5.  Chronopharmacokinetic studies of pranoprofen and procainamide.

Authors:  A Fujimura; H Kajiyama; Y Kumagai; H Nakashima; K Sugimoto; A Ebihara
Journal:  J Clin Pharmacol       Date:  1989-09       Impact factor: 3.126

Review 6.  Overview of patient compliance with medication dosing: a literature review.

Authors:  R N Greenberg
Journal:  Clin Ther       Date:  1984       Impact factor: 3.393

7.  Fluoxetine: clinical pharmacology and physiologic disposition.

Authors:  L Lemberger; R F Bergstrom; R L Wolen; N A Farid; G G Enas; G R Aronoff
Journal:  J Clin Psychiatry       Date:  1985-03       Impact factor: 4.384

  7 in total
  10 in total

1.  The pharmacokinetics of sertraline in overdose and the effect of activated charcoal.

Authors:  Joyce M Cooper; Stephen B Duffull; Ana S Saiao; Geoffrey K Isbister
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

2.  Predicting effect of food on extent of drug absorption based on physicochemical properties.

Authors:  Chong-Hui Gu; Hua Li; Jaquan Levons; Kimberley Lentz; Rajesh B Gandhi; Krishnaswamy Raghavan; Ronald L Smith
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.200

Review 3.  Chronopharmacokinetics. Current status.

Authors:  B Bruguerolle
Journal:  Clin Pharmacokinet       Date:  1998-08       Impact factor: 6.447

Review 4.  Spotlight on sertraline in the management of major depressive disorder in elderly patients.

Authors:  Richard B R Muijsers; Greg L Plosker; Stuart Noble
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 5.  The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders.

Authors:  G MacQueen; L Born; M Steiner
Journal:  CNS Drug Rev       Date:  2001

Review 6.  Clinical pharmacokinetics of sertraline.

Authors:  C Lindsay DeVane; Heidi L Liston; John S Markowitz
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

7.  Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants.

Authors:  Julian G Simmons; Pradeep J Nathan; Gregor Berger; Nicholas B Allen
Journal:  Psychopharmacology (Berl)       Date:  2011-04-05       Impact factor: 4.530

Review 8.  Effects of food on clinical pharmacokinetics.

Authors:  B N Singh
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

Review 9.  Sertraline: a review of its use in the management of major depressive disorder in elderly patients.

Authors:  Richard B R Muijsers; Greg L Plosker; Stuart Noble
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

10.  PharmGKB summary: sertraline pathway, pharmacokinetics.

Authors:  Rachel Huddart; J Kevin Hicks; Laura B Ramsey; Jeffrey R Strawn; D Max Smith; Margarita Bobonis Babilonia; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2020-02       Impact factor: 2.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.